Editorial: The relationship between diabetes and cancers and its underlying mechanisms.

Huo, Qiang; Wang, Jing; Zhang, Nannan; Xie, Long; Yu, Heshan; Li, Tao

Huo, Qiang; Wang, Jing; Zhang, Nannan; Xie, Long; Yu, Heshan; Li, Tao.

Afiliação

Huo Q; Clinical Research Center, Nanjing Jiangbei Hospital, Nanjing, China.
Wang J; Center for Translational Medicine, Zibo Central Hospital, Zibo, China.
Zhang N; Blood Purification Center, Zibo Central Hospital, Zibo, China.
Xie L; Department of Otolaryngology, Zibo Central Hospital, Zibo, China.
Yu H; Department of Oncology, Shibo High-Tech Hospital, Zibo, China.
Li T; Department of Breast and Thyroid Surgery, Zibo Central Hospital, Zibo, China.

Front Endocrinol (Lausanne) ; 13: 992569, 2022.

Article em En | MEDLINE | ID: mdl-36017321

Assuntos

Diabetes Mellitus Tipo 2; Neoplasias; Humanos; Hipoglicemiantes; Neoplasias/epidemiologia; Neoplasias/etiologia

Palavras-chave

antidiabetic drug; cancer development; cancer risk; diabetes; glucose metabolic disorder; thyroid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Neoplasias Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google